During the past decade, Apollo Hospital International Ltd. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Apollo Hospital International Ltd." #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Indian Society of Critical Care Medicine" with 1 trials sponsored, "Morphotek" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Hospital International Ltd." #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Hospital International Ltd." are "Critical Illness" (1 trials), "Episodic Migraine" (1 trials), "HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer" (1 trials), "Migraine" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Apollo Hospital International Ltd." in a lesser frequency.

Most popular intervention types in "Apollo Hospital International Ltd." are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Canasa" (1 trials), "Carboplatin" (1 trials), "Farletuzumab" (1 trials) and "Farletuzumab-matched placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Hospital International Ltd." are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Apollo Hospital International Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Apollo Hospital International Ltd., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Hospital International Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".